Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fortunato Ciardiello

Showing results (1-10 of 464) with videos related to

Pageof 47
Sort By:
The Lancet. Oncology|October 18, 2015
Maintenance therapy for metastatic colorectal cancerFortunato Ciardiello
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|November 6, 2002
The rational basis of using novel targeted biological agents in non-small cell lung cancerFortunato Ciardiello
Future Oncology (London, England)|March 25, 2006
Epidermal growth factor receptor inhibitors in cancer treatmentFortunato Ciardiello
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Why chemo-free treatment intervals can improve care of patients with metastatic colorectal cancerFortunato Ciardiello
Lancet (London, England)|June 18, 2023
Angiogenesis inhibition in metastatic colorectal cancer continuum of careErika Martinelli, Fortunato Ciardiello
Cancer Discovery|May 16, 2012
HER2 signaling and resistance to the anti-EGFR monoclonal antibody cetuximab: a further step toward personalized medicine for patients with colorectal cancerFortunato Ciardiello, Nicola Normanno
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2015
Optimizing Anti-EGFR Therapy in Colorectal CancerRamon Salazar, Fortunato Ciardiello
The Lancet. Oncology|December 7, 2017
The Cancer Moonshot from a European perspectiveFortunato Ciardiello, Josep Tabernero
Expert Opinion on Investigational Drugs|May 31, 2002
Anti-epidermal growth factor receptor drugs in cancer therapyFortunato Ciardiello, Giampaolo Tortora
Seminars in Oncology|August 15, 2003
Antisense strategies targeting protein kinase C: preclinical and clinical developmentGiampaolo Tortora, Fortunato Ciardiello
Pageof 47

Showing results (1-10 of 464) with videos related to

Sort By:
Pageof 47
The Lancet. Oncology|October 18, 2015
Maintenance therapy for metastatic colorectal cancerFortunato Ciardiello
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|November 6, 2002
The rational basis of using novel targeted biological agents in non-small cell lung cancerFortunato Ciardiello
Future Oncology (London, England)|March 25, 2006
Epidermal growth factor receptor inhibitors in cancer treatmentFortunato Ciardiello
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Why chemo-free treatment intervals can improve care of patients with metastatic colorectal cancerFortunato Ciardiello
Lancet (London, England)|June 18, 2023
Angiogenesis inhibition in metastatic colorectal cancer continuum of careErika Martinelli, Fortunato Ciardiello
Cancer Discovery|May 16, 2012
HER2 signaling and resistance to the anti-EGFR monoclonal antibody cetuximab: a further step toward personalized medicine for patients with colorectal cancerFortunato Ciardiello, Nicola Normanno
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2015
Optimizing Anti-EGFR Therapy in Colorectal CancerRamon Salazar, Fortunato Ciardiello
The Lancet. Oncology|December 7, 2017
The Cancer Moonshot from a European perspectiveFortunato Ciardiello, Josep Tabernero
Expert Opinion on Investigational Drugs|May 31, 2002
Anti-epidermal growth factor receptor drugs in cancer therapyFortunato Ciardiello, Giampaolo Tortora
Seminars in Oncology|August 15, 2003
Antisense strategies targeting protein kinase C: preclinical and clinical developmentGiampaolo Tortora, Fortunato Ciardiello
Pageof 47